## Abstract We investigated the risk of cancer after the diagnosis of Parkinson's disease (PD) through a historical cohort study. We used the medical recordsβlinkage system of the Rochester Epidemiology Project to identify all incident cases of PD in Olmsted County, Minnesota from 1976 through 1995
Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia
β Scribed by L. Joseph Melton III; Cynthia L. Leibson; Sara J. Achenbach; James H. Bower; Demetrius M. Maraganore; Ann L. Oberg; Walter A. Rocca
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 75 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In an inception cohort of 196 Olmsted County, Minnesota, residents with Parkinson's disease (PD) first recognized in 1976 to 1995, we tested whether the increased risk of bone fractures is associated with concomitant dementia. Using the data resources of the Rochester Epidemiology Project, information about PD, dementia, other clinical risk factors for fracture and fracture events was obtained from review of complete inpatient and outpatient medical records spanning each subject's residence in the community. Compared to an equal number of ageβ and sexβmatched nonβPD referent subjects from the community, PD patients were at a 2.2βfold increased risk of fractures generally and a 3.2βfold greater risk of hip fractures specifically. Adjusting for age, the independent predictors of overall fracture risk in the PD subjects included female sex (hazard ratio [HR] 1.6; 95% confidence interval [CI], 1.1β2.3), dementia (HR, 1.6; 95% CI, 1.1β2.4) and chronic depression, which was associated with a reduced risk (HR, 0.4; 95% CI, 0.2β0.8). Hip fractures were predicted by dementia (HR, 2.2; 95% CI, 1.2β4.1). The increased fracture risk in patients with PD is not entirely explained by concomitant dementia, and additional study is needed to determine the relative contributions to fracture risk of falls versus bone loss in these patients. Β© 2006 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Dementia is common in patients with Parkinson's disease (PDD). The etiology of PDD is still unclear, but exciting advances have been made in discovering pathogenetic components in Parkinson's disease (PD), implicating the role of genetic factors. It is, however, still controversial whet
## Abstract The objective of this cohort study was to determine the incidence of Parkinson's disease (PD) and the effects of race/ethnicity, other demographic characteristics, geography, and healthcare utilization on probability of diagnosis. The authors used the Pennsylvania state Medicaid claims
## Abstract An effect of subthalamic nucleus deep brain stimulation (STNβDBS) on cognition has been suspected but longβterm observations are lacking. The aim of this study was to evaluate the longβterm cognitive profile and the incidence of dementia in a cohort of Parkinson's disease (PD) patients
## Abstract The objective of this study is to compare the occurrence of dementia among Parkinson's disease (PD) patients treated with amantadine (AM group) with those never exposed to it (NoAM group). PD dementia shares neuroanatomical and biochemical similarities with Alzheimer's disease (AD). Mem